Medical experts insist on the benefits of booster doses for children who are eligible
2022-01-04T14:01:29.695Z
Amid the boom in the omicron variant and increased hospitalizations, the FDA approved the dose for youth ages 12 to 15 and immunocompromised children ages 5 to 11. In addition, the time between the second vaccine and the booster in adults is shortened.
